Skip to main content
. 2023 Jan 7;17(1):e13092. doi: 10.1111/irv.13092

FIGURE 2.

FIGURE 2

(A) Study design overview including participant‐level study flow of the test‐and‐treat strategy from 11/15/19 to 4/30/21. (B) Total number of participants completing intervention study procedure steps based on eligibility screening. ARI, acute respiratory illness; RT‐PCT, reverse transcription polymerase chain reaction